StocksFundsScreenerSectorsWatchlists
PRVA

PRVA - Privia Health Group, Inc. Stock Price, Fair Value and News

18.35USD-0.19 (-1.02%)Market Closed

Market Summary

PRVA
USD18.35-0.19
Market Closed
-1.02%

PRVA Alerts

  • 1 major insider sales recently.

PRVA Stock Price

View Fullscreen

PRVA RSI Chart

PRVA Valuation

Market Cap

2.2B

Price/Earnings (Trailing)

98.18

Price/Sales (Trailing)

1.31

EV/EBITDA

40.66

Price/Free Cashflow

26.97

PRVA Price/Sales (Trailing)

PRVA Profitability

EBT Margin

1.75%

Return on Equity

3.95%

Return on Assets

2.22%

Free Cashflow Yield

3.71%

PRVA Fundamentals

PRVA Revenue

Revenue (TTM)

1.7B

Rev. Growth (Yr)

20.97%

Rev. Growth (Qtr)

5.64%

PRVA Earnings

Earnings (TTM)

22.2M

Earnings Growth (Yr)

-79.72%

Earnings Growth (Qtr)

-33.44%

Breaking Down PRVA Revenue

Last 7 days

-1.7%

Last 30 days

-9.8%

Last 90 days

-14.3%

Trailing 12 Months

-25.8%

How does PRVA drawdown profile look like?

PRVA Financial Health

Current Ratio

1.81

PRVA Investor Care

Shares Dilution (1Y)

3.29%

Diluted EPS (TTM)

0.2

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20231.4B1.5B1.6B1.7B
20221.1B1.2B1.3B1.4B
2021817.7M860.2M904.6M966.2M
2020794.0M801.7M809.4M817.1M
2019000786.4M
2018000657.6M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Privia Health Group, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 02, 2024
mountcastle david
sold
-69,889
17.77
-3,933
evp & chief financial officer
Mar 11, 2024
sullivan william m
sold
-9,208
23.02
-400
-
Mar 08, 2024
mountcastle david
acquired
-
-
38,058
evp & chief financial officer
Mar 08, 2024
mehrotra parth
acquired
-
-
119,885
chief executive officer
Mar 08, 2024
sullivan william m
sold
-163,858
23.03
-7,115
-
Mar 08, 2024
fargis edward c
acquired
-
-
28,544
evp & general counsel
Jan 29, 2024
fargis edward c
acquired
-
-
44,404
evp & general counsel
Jan 25, 2024
sullivan william m
sold
-277,560
23.13
-12,000
-
Jan 24, 2024
sullivan william m
sold
-229,172
23.03
-9,951
-
Dec 28, 2023
sullivan william m
sold
-287,640
23.97
-12,000
-

1–10 of 50

Which funds bought or sold PRVA recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 12, 2024
AdvisorNet Financial, Inc
new
-
235
235
-%
Apr 10, 2024
PARK AVENUE SECURITIES LLC
added
3.1
-42,000
304,000
-%
Apr 09, 2024
MASSMUTUAL TRUST CO FSB/ADV
added
57.65
667
2,625
-%
Apr 09, 2024
Renaissance Capital LLC
sold off
-100
-1,642,020
-
-%
Apr 05, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC
reduced
-6.13
-188,009
744,890
-%
Apr 05, 2024
CWM, LLC
added
18.75
-
4,000
-%
Apr 05, 2024
GAMMA Investing LLC
added
26.88
3,302
17,474
-%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-10.26
-15,552
137,789
-%
Mar 21, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
new
-
1,036,350
1,036,350
-%
Mar 11, 2024
VANGUARD GROUP INC
added
2.49
6,648,280
259,740,000
0.01%

1–10 of 47

Are Funds Buying or Selling PRVA?

Are funds buying PRVA calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PRVA
No. of Funds

Unveiling Privia Health Group, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
9.55%
11,278,334
SC 13G
Feb 13, 2024
goldman sachs group inc
0.0%
41,373
SC 13G/A
Feb 09, 2024
fmr llc
-
0
SC 13G/A
Jan 23, 2024
blackrock inc.
14.5%
17,124,181
SC 13G/A
Jul 07, 2023
blackrock inc.
12.1%
13,938,867
SC 13G
Jun 12, 2023
fmr llc
-
0
SC 13G
May 15, 2023
durable capital partners lp
7.9%
9,090,909
SC 13G
May 12, 2023
pamplona capital partners iii, l.p.
0%
0
SC 13G/A
Feb 14, 2023
pamplona capital partners iii, l.p.
15.5%
17,741,723
SC 13G/A
Feb 14, 2023
goldman sachs group inc
21.7%
24,824,660
SC 13G/A

Recent SEC filings of Privia Health Group, Inc.

View All Filings
Date Filed Form Type Document
Apr 04, 2024
4
Insider Trading
Apr 04, 2024
ARS
ARS
Apr 04, 2024
DEF 14A
DEF 14A
Apr 04, 2024
DEFA14A
DEFA14A
Apr 02, 2024
144
Notice of Insider Sale Intent
Mar 22, 2024
PRE 14A
PRE 14A
Mar 15, 2024
4
Insider Trading
Mar 15, 2024
4
Insider Trading
Mar 15, 2024
4
Insider Trading
Mar 12, 2024
4
Insider Trading

Peers (Alternatives to Privia Health Group, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
410.7B
371.6B
-9.23% -12.95%
18.35
1.11
14.64% 11.24%
102.0B
195.3B
-0.90% 34.65%
18.99
0.52
8.17% -20.79%
86.8B
357.8B
-10.90% -7.68%
10.39
0.24
10.95% 93.52%
85.3B
65.0B
0.18% 18.00%
16.28
1.31
7.86% -7.11%
38.9B
154.0B
-3.67% 6.80%
14.39
0.25
6.54% 124.79%
11.5B
14.3B
-4.30% 22.39%
16.07
0.81
6.59% 6.24%
11.4B
12.1B
-4.93% 54.73%
16.48
0.94
4.57% 23.40%
MID-CAP
9.3B
2.3B
-4.81% 9.59%
34.17
4.11
6.06% 9.17%
6.7B
2.9B
-6.00% -3.46%
-311.45
2.3
12.20% -107.93%
2.2B
1.4B
-1.50% 0.56%
35.86
1.57
21.19% 34.42%
2.2B
3.8B
-2.74% -34.13%
10.27
0.57
-27.73% -52.50%
SMALL-CAP
1.6B
1.1B
0.06% -12.91%
25.13
1.48
11.31% 35.83%
1.2B
3.0B
5.33% 55.67%
-6.33
0.4
6.74% 20.73%
48.4M
-
-23.65% -14.81%
-3.31
-
- -12.94%
18.2M
21.3M
11.67% 2.14%
34.08
0.85
8.00% -62.25%

Privia Health Group, Inc. News

Latest updates
MarketBeat11 Apr 202411:52 am

Privia Health Group, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42018Q4
Revenue5.6%440,828,000417,282,000413,351,000386,276,000364,424,000342,899,000335,536,000313,801,000275,333,000251,524,000225,756,000213,607,000213,699,000207,170,000183,264,000212,942,000--
Operating Expenses6.7%439,408,000411,746,000406,372,000379,562,000362,175,000347,473,000340,786,000325,348,000294,680,000264,333,000418,943,000205,700,000209,537,000198,627,000177,085,000206,446,000--
  S&GA Expenses-13.7%6,249,0007,241,0005,956,0005,286,0005,173,0005,088,0004,819,0004,661,0003,800,0004,588,00011,178,0003,184,0003,962,0002,709,0002,220,0002,452,000--
EBITDA Margin2.9%0.030.030.020.01-0.01-0.03-0.04-0.22-0.22-0.22-0.200.03------
Interest Expenses-1.6%2,848,0002,894,000817,0001,813,0001,152,000285,000-663,000-232,000-185,000-292,000-302,000-291,000-437,000-504,000-509,000-467,000--
Income Taxes-20.2%1,986,5002,488,0001,400,0002,125,000-13,447,000-4,845,0005,468,0006,308,000-7,643,000-2,210,000-20,004,0002,000,000-67,000-8,561,000500,000700,000--
Earnings Before Taxes-49.4%4,268,0008,430,0007,796,0008,527,0003,401,000-4,289,000-5,913,000-11,779,000-19,532,000-13,101,000-193,489,0007,616,0003,725,0008,039,0005,670,0006,029,000--
EBT Margin-1.7%0.020.020.010.00-0.01-0.03-0.04-0.22-0.23-0.22-0.200.03------
Net Income-33.4%3,756,0005,643,0006,360,0006,402,00018,517,5001,624,000-11,381,000-18,087,000-11,612,500-9,115,000-173,485,0005,616,0003,949,00016,685,0005,196,0005,329,000--
Net Income Margin-42.7%0.010.020.020.01-0.01-0.03-0.04-0.20-0.20-0.19-0.170.04------
Free Cashflow185.5%64,078,00022,443,0007,535,000-13,384,00029,139,00016,129,0007,178,000-5,354,000-12,471,00062,454,0007,004,000-2,476,000------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42019Q4
Assets0.8%1,000992938875793808745723686632597348329270
  Current Assets0.4%701698654589552580521493447469436205190130
    Cash Equivalents17.9%39033031831134831729231632136230082.0085.0047.00
  Net PPE-10.5%2.003.003.003.003.004.004.004.005.004.004.005.005.006.00
  Goodwill2.3%1391361358.001271271271288.008.00119119119119
Liabilities-2.2%393401366319274317278265236227208199185163
  Current Liabilities-1.8%387394358310264305265220190187167158147115
Shareholder's Equity3.1%561545571557499491467458450405389149144107
  Retained Earnings1.4%-193-196-202-209-216-234-236-225-208-196-187-14.48-19.88-51.10
  Additional Paid-In Capital1.9%754740726721715704680660634606579166166160
Shares Outstanding0.2%11811811711511510910910810310299.0096.00--
Minority Interest-0.9%46.0046.0046.0043.0020.0021.0022.0023.0023.00-5.60-3.83-2.88-3.10-2.76
Float---2,200---1,470---1,420---
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42018Q4
Cashflow From Operations185.4%64,10122,4617,607-13,38429,15416,1457,217-5,320-12,32062,6517,203-2,476-3,33935,54013,769-7,079--
  Share Based Compensation8.0%11,66910,8019,2475,3819,17514,83318,47024,88125,07025,800202,560101121121121121--
Cashflow From Investing61.4%-5,023-13,020-72.00-24,856-15.00-16.00-39.00-34.00-32,379-197-199---1.00-366-13.00--
Cashflow From Financing-98.6%42.003,005-8191,4771,9578,574-30,9137053,164-93.00210,809-219-219-10,110-43810,000--

PRVA Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Revenue$ 1,657,737$ 1,356,660$ 966,220
Operating expenses:   
Provider expense1,298,5731,051,040727,827
Cost of platform197,663170,838174,731
Sales and marketing24,73219,74122,750
General and administrative109,587129,592255,884
Depreciation and amortization6,5334,5712,464
Total operating expenses1,637,0881,375,7821,183,656
Operating income (loss)20,649(19,122)(217,436)
Interest (income) expense, net(8,372)(542)1,070
Income (loss) before provision for (benefit from) income taxes29,021(18,580)(218,506)
Provision for (benefit from) income taxes7,993(6,516)(27,857)
Net income (loss)21,028(12,064)(190,649)
Less: Loss attributable to non-controlling interests(2,051)(3,479)(2,419)
Net income (loss) income attributable to Privia Health Group, Inc.$ 23,079$ (8,585)$ (188,230)
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders – basic (in dollars per share)$ 0.20$ (0.08)$ (1.83)
Net income (loss) income per share attributable to Privia Health Group, Inc. stockholders – diluted (in dollars per share)$ 0.19$ (0.08)$ (1.83)
Weighted average common shares outstanding - basic (in shares)116,731,406110,695,266102,952,370
Weighted average common shares outstanding – diluted (in shares)124,686,067110,695,266102,952,370

PRVA Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 389,511$ 347,992
Accounts receivable290,768189,604
Prepaid expenses and other current assets20,52514,366
Total current assets700,804551,962
Non-current assets:  
Property and equipment, net2,3253,386
Right-of-use asset6,6128,089
Intangible assets, net107,63057,387
Goodwill138,749126,938
Deferred tax asset35,20040,368
Other non-current assets8,5804,683
Total non-current assets299,096240,851
Total assets999,900792,813
Current liabilities:  
Accounts payable and accrued expenses57,83152,837
Provider liability326,078208,424
Operating lease liabilities, current3,0433,013
Total current liabilities386,952264,274
Non-current liabilities:  
Operating lease liabilities, non-current5,2468,490
Other non-current liabilities3131,000
Total non-current liabilities5,5599,490
Total liabilities392,511273,764
Commitments and contingencies (Note 14)
Stockholders’ equity:  
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 118,216,979 and 114,690,808 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively1,1821,148
Additional paid-in capital753,869714,639
Accumulated deficit(193,614)(216,693)
Total Privia Health Group, Inc. stockholders’ equity561,437499,094
Non-controlling interest45,95219,955
Total stockholders’ equity607,389519,049
Total liabilities and stockholders’ equity$ 999,900$ 792,813
PRVA
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.
 CEO
 WEBSITEpriviahealth.com
 INDUSTRYHealthcare Plans
 EMPLOYEES964

Privia Health Group, Inc. Frequently Asked Questions


What is the ticker symbol for Privia Health Group, Inc.? What does PRVA stand for in stocks?

PRVA is the stock ticker symbol of Privia Health Group, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Privia Health Group, Inc. (PRVA)?

As of Mon Apr 15 2024, market cap of Privia Health Group, Inc. is 2.18 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PRVA stock?

You can check PRVA's fair value in chart for subscribers.

What is the fair value of PRVA stock?

You can check PRVA's fair value in chart for subscribers. The fair value of Privia Health Group, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Privia Health Group, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PRVA so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Privia Health Group, Inc. a good stock to buy?

The fair value guage provides a quick view whether PRVA is over valued or under valued. Whether Privia Health Group, Inc. is cheap or expensive depends on the assumptions which impact Privia Health Group, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRVA.

What is Privia Health Group, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Mon Apr 15 2024, PRVA's PE ratio (Price to Earnings) is 98.18 and Price to Sales (PS) ratio is 1.31. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRVA PE ratio will change depending on the future growth rate expectations of investors.